Rekodi ya ushahidi wa mbinu

Medication Adherence Rating Scale

The Medication Adherence Rating Scale (MARS) is a 10-item self-report measure developed by Thompson, Kulkarni, and Sergejew in 2000 to assess medication adherence behaviors and attitudes in psychiatric populations, particularly antipsychotic medication use. Although originally validated in schizophrenia, it has been successfully applied across diverse medical conditions including hypertension, diabetes, and chronic disease management, providing a quick, sensitive assessment of actual adherence frequency and admission of problematic medication-taking behaviors.

Sources recorded, not reviewed

Rekodi ya chanzo

Nukuu zimehamishwa kwa uhalisi kutoka kwa rekodi ya chanzo cha mbinu. Hakuna uthibitisho wa kiwango cha dai unaodokezwa kutoka kwao.

Medication Adherence Rating Scale (MARS)

Rekodi ya mbinu ya kiajenda · process-pipeline / pharmacology

Thompson, K., Kulkarni, J., & Sergejew, A. A. (2000). Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophrenia Research, 42(3), 241-247. · DOI 10.1016/s0920-9964(99)00130-9

Fungua mbinu kamili

Madai yaliyotunzwa

Madai yamehifadhiwa katika daftari la ushahidi, kila moja ikiwa na tathmini yake.

Hakuna madai yaliyotunzwa bado

Mwonekano huu haubuni tathmini ya dai wakati daftari haina yoyote.

Mbinu zinazohusiana

Zilizotengenezwa kutoka kwa grafu ya mbinu na kuonyeshwa kama uhusiano uliopendekezwa na mashine — hakuna dai la ushahidi linalodokezwa.

Same method familyBeliefs about Medicines Questionnairemachine-suggested · Relational suggestion, not evidence.Same method familyDrug Attitude Inventorymachine-suggested · Relational suggestion, not evidence.Same method familySelf-Efficacy for Appropriate Medication Use Scalemachine-suggested · Relational suggestion, not evidence.Same method familyTreatment Satisfaction Questionnaire for Medicationmachine-suggested · Relational suggestion, not evidence.